Group One Trading’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$6.77K | – | 8538 |
|
|
2025
Q4 | $6.77K | Buy |
+200
| New | +$6.21K | ﹤0.01% | 7036 |
|
|
2025
Q1 | – | Sell |
-20,113
| Closed | -$254K | – | 8242 |
|
|
2024
Q4 | $254K | Buy |
+20,113
| New | +$255K | ﹤0.01% | 3747 |
|
|
2024
Q3 | – | Sell |
-3,625
| Closed | -$88.5K | – | 7239 |
|
|
2024
Q2 | $88.5K | Buy |
3,625
+337
| +10% | +$15.6K | ﹤0.01% | 4060 |
|
|
2024
Q1 | $236K | Buy |
3,288
+1,875
| +133% | +$261K | ﹤0.01% | 3414 |
|
|
2023
Q4 | $281K | Buy |
1,413
+1,163
| +465% | +$144K | ﹤0.01% | 3557 |
|
|
2023
Q3 | $33.2K | Buy |
250
+212
| +558% | +$34.6K | ﹤0.01% | 5459 |
|
|
2023
Q2 | $5.61K | Sell |
38
-600
| -94% | -$93.5K | ﹤0.01% | 6675 |
|
|
2023
Q1 | $93.6K | Buy |
+638
| New | +$129K | ﹤0.01% | 4361 |
|
|
2021
Q4 | – | Sell |
-138
| Closed | -$34K | – | 8737 |
|
|
2021
Q3 | $34K | Sell |
138
-18,762
| -99% | -$4.96M | ﹤0.01% | 6833 |
|
|
2021
Q2 | $4.81M | Buy |
+18,900
| New | +$3.53M | 0.01% | 1725 |
|
Group One Trading's RAPT Position: Q1 2026 in Review
Group One Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 5,282 shares — an estimated $179K sold.
Group One Trading first reported a position in RAPT in Q4 2020 and held it in 7 quarters. The position peaked at $179K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Group One Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 5,282 RAPT Therapeutics shares in Q1 2026, an estimated $179K.
- Group One Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 7 quarters.
- Group One Trading's RAPT Therapeutics position peaked at $179K in Q4 2025.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.